My research program focuses on three main areas in health and biotechnology law and policy:
Knowledge translation in health, biotechnology and new technologies in biomedicine: This area of research explores how health and biotechnology research is represented by the research community, industry, politicians, policy makers, the popular media, internet sites and other public venues. My research compares the translational layers between these stakeholder groups, using a combination of qualitative (key informant interviews and focus groups) and quantitative research methods (lexicographic analysis, text coding, and statistical modelling). My research group analyses social and traditional media.
Impacts of innovation, commercialization/open science and intellectual property policies on scientific culture and the conduct of translational research and clinical trials: My research group has developed a range of novel bibliometric and scientometric methods to address policy questions. We use these in combination with more traditional methods such as surveys, key informant interviews, social network analysis, and statistical modelling.
Use of commons theory to analyze the institutional development and governance of bioresource and data repositories for biomedical research: This research also addresses access and benefit sharing and research partnerships between developed and developing countries.
